106 related articles for article (PubMed ID: 8636278)
1. Proteolysis of insulin-like growth factor-binding protein-3 in the male reproductive tract.
Plymate SR; Rosen CJ; Paulsen CA; Ware JL; Chen J; Vessella RE; Birnbaum RS
J Clin Endocrinol Metab; 1996 Feb; 81(2):618-24. PubMed ID: 8636278
[TBL] [Abstract][Full Text] [Related]
2. Identification of insulin-like growth factor-binding protein-3 (IGFBP-3) fragments and IGFBP-5 proteolytic activity in human seminal plasma: a comparison of normal and vasectomized patients.
Lee KO; Oh Y; Giudice LC; Cohen P; Peehl DM; Rosenfeld RG
J Clin Endocrinol Metab; 1994 Nov; 79(5):1367-72. PubMed ID: 7525634
[TBL] [Abstract][Full Text] [Related]
3. Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma.
Cohen P; Graves HC; Peehl DM; Kamarei M; Giudice LC; Rosenfeld RG
J Clin Endocrinol Metab; 1992 Oct; 75(4):1046-53. PubMed ID: 1383255
[TBL] [Abstract][Full Text] [Related]
4. The insulin-like growth factor system in human peritoneal fluid: its effects on endometrial stromal cells and its potential relevance to endometriosis.
Giudice LC; Dsupin BA; Gargosky SE; Rosenfeld RG; Irwin JC
J Clin Endocrinol Metab; 1994 Nov; 79(5):1284-93. PubMed ID: 7525631
[TBL] [Abstract][Full Text] [Related]
5. Biochemical analysis of prostate specific antigen-proteolyzed insulin-like growth factor binding protein-3.
Fielder PJ; Rosenfeld RG; Graves HC; Grandbois K; Maack CA; Sawamura S; Ogawa Y; Sommer A; Cohen P
Growth Regul; 1994 Dec; 4(4):164-72. PubMed ID: 7538844
[TBL] [Abstract][Full Text] [Related]
6. A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin.
Lalou C; Lassarre C; Binoux M
Endocrinology; 1996 Aug; 137(8):3206-12. PubMed ID: 8754741
[TBL] [Abstract][Full Text] [Related]
7. Acid-activated insulin-like growth factor binding protein protease activity of cathepsin D in normal and malignant prostatic epithelial cells and seminal plasma.
Nunn SE; Peehl DM; Cohen P
J Cell Physiol; 1997 May; 171(2):196-204. PubMed ID: 9130467
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor binding protein-3 proteolysis in children with insulin-dependent diabetes mellitus: a possible role for insulin in the regulation of IGFBP-3 protease activity.
Bereket A; Lang CH; Blethen SL; Fan J; Frost RA; Wilson TA
J Clin Endocrinol Metab; 1995 Aug; 80(8):2282-8. PubMed ID: 7543110
[TBL] [Abstract][Full Text] [Related]
9. Increased proteolysis of insulin-like growth factor-binding protein-3 (IGFBP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29-kilodalton (kDa) glycosylated IGFBP-3 fragment contained in the approximately 130- to 150-kDa ternary complex.
Bang P; Brismar K; Rosenfeld RG
J Clin Endocrinol Metab; 1994 May; 78(5):1119-27. PubMed ID: 7513716
[TBL] [Abstract][Full Text] [Related]
10. 7S nerve growth factor is an insulin-like growth factor-binding protein protease.
Rajah R; Bhala A; Nunn SE; Peehl DM; Cohen P
Endocrinology; 1996 Jul; 137(7):2676-82. PubMed ID: 8770886
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor (IGF) I and II, IGF-binding proteins, and IGF-binding protein proteases are produced by theca and stroma of normal and polycystic human ovaries.
Mason HD; Cwyfan-Hughes SC; Heinrich G; Franks S; Holly JM
J Clin Endocrinol Metab; 1996 Jan; 81(1):276-84. PubMed ID: 8550764
[TBL] [Abstract][Full Text] [Related]
12. Measurement and characterization of insulin-like growth factor binding protein-3 in human biological fluids: discrepancies between radioimmunoassay and ligand blotting.
Gargosky SE; Pham HM; Wilson KF; Liu F; Giudice LC; Rosenfeld RG
Endocrinology; 1992 Dec; 131(6):3051-60. PubMed ID: 1280211
[TBL] [Abstract][Full Text] [Related]
13. Measurement of intact insulin-like growth factor-binding protein-3 in human plasma using a ligand immunofunctional assay.
Lassarre C; Binoux M
J Clin Endocrinol Metab; 2001 Mar; 86(3):1260-6. PubMed ID: 11238518
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of insulin-like growth factor (IGF)-binding protein-3 and its proteolytic fragments on ligand binding, cell surface association, and IGF-I receptor signaling.
Devi GR; Yang DH; Rosenfeld RG; Oh Y
Endocrinology; 2000 Nov; 141(11):4171-9. PubMed ID: 11089550
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.
Freda PU; Post KD; Powell JS; Wardlaw SL
J Clin Endocrinol Metab; 1998 Nov; 83(11):3808-16. PubMed ID: 9814451
[TBL] [Abstract][Full Text] [Related]
16. Prostate-specific antigen and other prostate-derived proteases cleave IGFBP-3, but prostate cancer is not associated with proteolytically cleaved circulating IGFBP-3.
Koistinen H; Paju A; Koistinen R; Finne P; Lövgren J; Wu P; Seppälä M; Stenman UH
Prostate; 2002 Feb; 50(2):112-8. PubMed ID: 11816019
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and IGFBP proteases in human synovial fluid.
Matsumoto T; Gargosky SE; Iwasaki K; Rosenfeld RG
J Clin Endocrinol Metab; 1996 Jan; 81(1):150-5. PubMed ID: 8550744
[TBL] [Abstract][Full Text] [Related]
18. Not all insulin-like growth factor-binding proteins (IGFBPs) are detectable by western ligand blotting: case studies of PC12 pheochromocytoma and rat anterior pituitary IGFBPs and proteolyzed IGFBP-3.
Ocrant I; Fay CT; Pham H; Rosenfeld RG
Endocrinology; 1992 Jul; 131(1):221-7. PubMed ID: 1377122
[TBL] [Abstract][Full Text] [Related]
19. Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients.
Cohen P; Peehl DM; Stamey TA; Wilson KF; Clemmons DR; Rosenfeld RG
J Clin Endocrinol Metab; 1993 Apr; 76(4):1031-5. PubMed ID: 7682560
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the developmental and nutritional changes in porcine insulin-like growth factor-binding protein-1 and -2 serum levels by immunoassay.
McCusker RH; Cohick WS; Busby WH; Clemmons DR
Endocrinology; 1991 Nov; 129(5):2631-8. PubMed ID: 1718730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
